Earlier this month, the newly spun-off GE HealthCare revealed its second planned acquisition as an independent company
Share: email Subscribe
Weekly Top Stories Tue, 28 Feb 2023
We have 30 articles this week #Horizon Therapeutics shareholders overwhelmingly approve acquisition by Amgen. #Jounce Slashes 57% of Staff, Drops Assets in Stock Merger with Redx. Get Ready for the Future of Mobile Medical Imaging: #Modular Devices Acquires Interim Diagnostic Imaging! #VBL Therapeutics and #Notable Labs Announce Definitive Merger Agreement. #Enliven Therapeutics Closes Merger with #Imara and Private Placement of $165 Million. #Kite Completes Acquisition of #Tmunity. #Transcend Therapeutics, a mental health-focused biotechnology company, announces a Series A funding round of $40 million led by Alpha Wave Global and Integrated Investment Partners. #Vytalize Health Closes $100M to Support Value-Based Care Transformation.
Editor's Choice
1. 
Clinician Engagement is Key for Success with Healthcare AI
2. 
ObvioHealth Launches Digital Therapeutics API for Clinical Trials
3. 
Ambience Healthcare Launches Automated AI Medical Scribe Platform
4. 
RapidAI Receives FDA 510(K) for Another Pulmonary Embolism Tool
5. 
Bluestem Health Launches AI-Based Virtual Healthcare Assistant Powered By Mediktor
6. 
Utilizing Robotics and Predictive Analytics to Transform Care
Top 10 M&A Transactions
7. 
Horizon Therapeutics Shareholders Overwhelmingly Approve the Acquisition By Amgen
8. 
Jounce Slashes 57% of Staff, Drops Assets in Stock Merger with Redx
9. 
Get Ready for the Future of Mobile Medical Imaging: Modular Devices Acquires Interim Diagnostic Imaging!
10. 
VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement
11. 
Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million
12. 
Kite Completes Acquisition of Tmunity
13. 
Amazon Closes $3.9B Acquisition of One Medical
14. 
Aledade Acquires Curia, Adds More Than 450 New Practices
15. 
AGS Acquires Offshore Patient Access BPO Unit from Availity
16. 
Ipsen Extends Expiration Date of Tender Offer for Albireo Pharma, Inc. to 1 March 2023
Top 4 Venture Funding
17. 
Transcend Therapeutics, a Mental Health-focused Biotechnology Company, Announces Series a Funding Round of $40 Million Led By Alpha Wave Global and Integrated Investment Partners
18. 
Vytalize Health Closes $100M to Support Value-based Care Transformatio
19. 
UnitedHealth Closes $5.4 Billion Deal with LHS
20. 
Axena Health Raises $25M to Support Pelvic Floor Digital Therapeutic
Top 4 Partnerships Announcements
21. 
Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials
22. 
Dawn Health, Novartis Partner to Develop Chronic Condition Management Tools
23. 
Mark Cuban Cost Plus Drug Company Partners with Diabetes Management Platform
24. 
Apax Partners Acquires a Majority Stake in Porsolt to Support Its Growth Strategy to Become a Global Leader in Preclinical Services.
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us